Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 4, 2004, Pages 357-362

  Klinkert, P ^a   Post, P N ^b   Breslau, P J ^a   van Bockel, J H ^b  

^a Red Cross Hospital Den Haag   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood vessel prosthesis; Polytetrafluoroethylene; Review; Saphenous vein; Vascular; Vascular patency

Indexed keywords

POLITEF;

ARTERY BYPASS; AUTOGRAFT; BYPASS SURGERY; CONTROLLED STUDY; FEMOROPOPLITEAL BYPASS; GRAFT PATENCY; GRAFT REJECTION; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MEDICAL LITERATURE; MEDLINE; POLITEF IMPLANT; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS MATERIAL; RETROSPECTIVE STUDY; REVIEW; SAPHENOUS VEIN GRAFT; SURGICAL TECHNIQUE; VEIN GRAFT;

EID: 1642310221     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2003.12.027     Document Type: Review

References (37)

1. Kunlin J. Le traitement de l'ischemic arteritique par la greffe veineuse longue. Rev Chir Paris 1951; 70:206-236.
2. Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery 1982; 92: 921-930.
3. Illig KA, Green RM. Prosthetic above-knee femoropopliteal bypass. Semin Vasc Surg 1999; 12:38-45.
4. O'Riordain DS, Buckley DJ, O'Donnell JA. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 1992; 164:129-131.
5. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992; 16:209-217.
6. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517-538.
7. Connolly JE, Kwaan JH. In situ saphenous vein bypass. Arch Surg 1982; 117:1551-1557.
8. Porter JM. In situ versus reversed vein graft: is one superior? J Vasc Surg 1987; 5:779-780.
9. Taylor Jr LM, Edwards JM, Phinney ES, Porter JM. Reversed vein bypass to infrapopliteal arteries. Modern results are superior to or equivalent to in-situ bypass for patency and for vein utilization. Ann Surg 1987; 205:90-97.
10. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York: The Russell Sage Foundation, 1994:194-213.
11. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 1999; 126:594-601.
12. Achermann A, Gurke L, Stirnemann P. Der supragenikulare Bypass: Die Vene im Vergleich mit der Fremdmaterial-Prothese (PTFE). Swiss Surg 1998; 4:129-132.
13. Berlakovich GA, Herbst F, Mittlbock M, Kretschmer G. The choice of material for above-knee femoropopliteal bypass. A 20-year experience. Arch Surg 1994; 129:297-302.
14. John TG, Stonebridge PA, Kelman J, Murie JA, Jenkins AM, Ruckley CV. Above-knee femoropopliteal bypass grafts and the consequences of graft failure. Ann R Coll Surg Engl 1993; 75: 257-260.
15. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous; vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000; 32:268-277.
16. Kent KC, Donaldson MC, Attinger CE, Couch NP, Mannick JA, Whittemore AD. Femoropopliteal reconstruction for claudication. The risk to life and limb. Arch Surg 1988; 123:1196-1198.
17. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986; 3:104-114.
18. Aalders GJ, Van Vroonhoven TJ. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial. J Vasc Surg 1992; 16:816-823.
19. Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-knee Femoropopliteal Study Group. J Vasc Surg 1997; 25: 19-28.
20. Burger DH, Kappetein AP, Van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 2000; 32:278-283.
21. Allen BT, Reilly JM, Rubin BG, Thompson RW, Anderson CB, Flye MW et al. Femoropopliteal bypass for claudication: vein vs PTFE. Ann Vasc Surg 1996; 10:178-185.
22. Davies MG, Feeley TM, O'Malley MK, Colgan MP, Moore DJ, Shanik GD. Infrainguinal polytetrafluoroethylene grafts: saved limbs or wasted effort? A report on ten years' experience. Ann Vasc Surg 1991; 5:519-524.
23. Kavanagh EG, O'Riordain DS, Buckley DJ, O'Donnell JA. Long term results of polytetrafluoroethylene in above knee femoropopliteal bypass for critical ischaemia. Ir J Med Sci 1998; 167:221-224.
24. O'Donnell Jr TF, Farber SP, Richmand DM, Deterling RA, Callow AD. Above-knee polytetrafluoroethylene femoropopliteal bypass graft: is it a reasonable alternative to the below-knee reversed autogenous vein graft? Surgery 1983; 94:26-31.
25. Patterson RB, Fowl RJ, Kempczinski RF, Gewirtz R, Shukla R. Preferential use of EPTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg 1990; 4:338-343.
26. Plecha EJ, Freischlag JA, Seabrook GR, Towne JB. Femoropopliteal bypass revisited: an analysis of 138 cases. Cardiovasc Surg 1996; 4:195-199.
27. Rosenthal D, Evans RD, McKinsey J, Seagraves MA, Lamis PA, Clark NM et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg (Torino) 1990; 31:462-468.
28. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1997; 26: 543-550.
29. Woratyla SP, Darling III RC, Chang BB, Paty PS, Kreienberg PB, Leather RP et al. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee. Am J Surg 1997; 174:169-172.
30. Archie JP. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann Vasc Surg 1994; 8:475-484.
31. Buchbinder D, Lloyd WE, Shah DM, Rollins DL, Semrow C, Leather RP. The in situ bypass above the knee. Ann Vasc Surg 1989; 3:210-213.
32. Evans LE, Webster MW, Brooks DH, Bahnson HT. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. Surgery 1981; 89:16-72.
33. Gupta SK, Veith FJ, Kram HB, Wengerter KR. Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: a preliminary report. J Vasc Surg 1991; 13:163-172.
34. Harris JP, O'Brien CJ, Stephen MS, Sheil AG, May J. Should polytetrafluoroethylene grafts be used in preference to saphenous vein for femoropopliteal arterial bypass? Aust N Z J Surg 1985; 55:579-583.
35. Michaels JA. Choice of material for above-knee femoropopliteal. bypass graft. Br J Surg 1989; 76:7-14.
36. Mamode N, Scott RN. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2000; 19:CD001487.
37. Klinkert P, Schepers A, Burger DH, Van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 2003; 37:149-155.